Salt Composition in both
Sulfamethoxazole 800mg + Trimethoprim 160mg
Salt Composition
(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Co Trimoxazole DS 800/160mg Tablet 10s
1,696+ Customers trust this
WHO GMP Certified
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
YesNoAstraZeneca, a global leader in pharmaceuticals, is looking to diversify its global portfolio of products to help protect its investment opportunities. It is acquiring Bactrim Pharmaceuticals, an innovative combination antibiotic and antibiotic formulation company that will be based in New York, New York and Puerto Rico. It has already established a strong track record in developing complex, high-quality combination oral antibiotics. These products have proven effective in combating bacterial infections, and are being sold in more than 100 countries. Bactrim has been a vocal success story for the pharmaceutical industry, with over 1,500 new pharmaceuticals being launched in its first 12 months.
As part of the acquisition, AstraZeneca will also focus on developing an innovative, high-quality combination oral antibiotic formulation. The combination drug, which is a combination of trimethoprim/sulfamethoxazole (TMP/SMX), ticlopidine (TMP/SMX) and clindamycin (TMP/SMX), will also include metronidazole (TMP/SMX) and trimethoprim/sulfamethoxazole (TMP/SMX) as well as ticlid, a combination antibiotic used to treat many types of infections. Bactrim and AstraZeneca are close partners in this innovative development effort. Bactrim has an established presence in the United States, with more than 40 countries in the developing world. As part of its efforts to diversify its portfolio of products, AstraZeneca also is developing a novel, high-quality combination oral antibiotic formulation that will include metronidazole, trimethoprim/sulfamethoxazole (TMP/SMX) and metronidazole, an antibiotic that treats various bacterial infections. The combination antibiotic, which is sold under the brand name Bactrim, is currently being studied for its effectiveness in treating bacterial infections. The Bactrim portfolio is currently valued at $2.6 billion and is expected to grow to $3.3 billion by 2028. The combination formulation, which is marketed under the brand name Bactrim DS, is one of the top three active ingredients in the Bactrim DS combination product, with the company generating a reported revenue of $4.4 billion in the 12-month period ending Dec 2011.
The Bactrim portfolio, which includes the combination formulation Bactrim DS-SUM, is currently valued at approximately $1.8 billion, and is expected to grow to $2.2 billion by 2028. Bactrim’s portfolio of products is based on high-quality combination antibiotic formulations that are being developed to target multiple infections, and are being sold in more than 100 countries. AstraZeneca and Bactrim are closely collaborating to create Bactrim’s top-rated combination oral antibiotic portfolio. AstraZeneca is the only pharmaceutical company that has achieved this, and Bactrim is the world’s leading pharmaceutical company. The Bactrim portfolio is also focused on the development and manufacture of combination oral and intravenous formulations, with Bactrim producing the most complex combination oral antibiotics. These products are manufactured using the same active ingredients in the Bactrim DS formulation, but are formulated using the same combination of two active ingredients and are in the process of development and manufacture. The Bactrim portfolio is in the process of commercializing Bactrim DS, and is in the process of commercializing the next generation combination oral antibiotic, the Bactrim DS-SUM. The Bactrim portfolio is currently valued at approximately $1.7 billion, and is expected to grow to $2.6 billion by 2028. Bactrim’s portfolio of products is focused on the development and manufacture of combination oral and intravenous formulations, and is being studied for its effectiveness in treating bacterial infections. AstraZeneca and Bactrim are working with the pharmaceutical industry to develop new products for the treatment of various infections, and are working with the pharmaceutical industry to develop and commercialize Bactrim DS-SUM.
Bactrim has a robust pipeline, with the company having invested approximately $25 billion in R& D for the past 12 years. The company has extensive experience in developing complex combination oral and IV antibiotic formulations, including the combination of trimethoprim/sulfamethoxazole (TMP/SMX), ticlid, and metronidazole, as well as several other pharmaceuticals. The Bactrim portfolio is an important part of the pharmaceutical industry, with a strong presence in the developing world, and is well-positioned to be a leader in its future.
Bactrim and Mycoplasma Infections
Medications and vaccines for bacterial infections.
A total of 24 new bacterial infections were reported in the US in January 2024. These cases were identified as “Bactrim”, “Mycoplasma” and “Mycoplasma genitalium”. The number of bacterial infections reported was similar for all the drugs studied. However, the reported number of bacterial infections was higher for the Mycoplasma and Mycoplasma genitalium drugs. This was attributed to the higher bacterial load of the Mycoplasma and Mycoplasma genitalium. The higher bacteria found in patients with Mycoplasma and Mycoplasma genitalium infections was due to the higher infection load of these drugs. The higher bacterial load of the Mycoplasma and Mycoplasma genitalium was due to the higher bacterial infection in patients with Mycoplasma and Mycoplasma genitalium infections. In the US, the Mycoplasma and Mycoplasma infections are caused byMycoplasma genitalium, and the Mycoplasma and Mycoplasma genitalium infections are caused byMycoplasma pneumoniae. The Mycoplasma and Mycoplasma genitalium infections are caused byM. pneumoniaeA combination of these two bacteria strains is responsible for the majority of bacterial infections. These bacterial infections may be caused byOther bacteria that can cause bacterial infections includeP. falciparum, P. ovale, P. krusei, P.Staphylococcus, andStreptococcusIn the US, the Mycoplasma infection is a combination ofandgenitalium
Precautionary Information:This information is not an exhaustive guide for each patient, as some infections may require an antibiotic. The patient must have been exposed to the drug and should not be treated by others in the same way. Patients should be advised to seek medical advice if they are unable to tolerate the drug or have an allergic reaction.
The drug of choice is a combination of amoxicillin and clavulanic acid. The combination of amoxicillin and clavulanic acid is not recommended in patients receiving a course of antibiotics. Patients should be monitored closely for signs of an allergic reaction, particularly if they are allergic to any antibiotics or have any history of allergies to cephalosporin antibiotics, cephalosporin drugs, or penicillins.
Interactions:All drugs may affect the levels of the drug of choice. In some cases, the drug of choice may increase the risk of side effects. If a patient develops a severe allergic reaction after taking the drug, immediate medical attention should be sought immediately. The patient should be informed about all precautions and warnings necessary for the patient to follow-up with the doctor.
References:• Bactrim: Pharmacological properties of amoxicillin • Mycoplasmas: antibacterial drugs • Mycoplasma: antibacterial drugs • Mycoplasma genitalium: antibacterial drugs • Mycoplasma pneumoniae: antibacterial drugs • Mycoplasma pneumoniae: antibacterial drugs
For more information visit the CDC websiteThe content on this page has been supplied by the manufacturers, which may contain information from various sources, including the U. S. Copyright © 2024 CVS Health. For more information, or to submit changes to the information, please send a message to: or email [email protected]. Our goal is to provide information that is free for individuals and their pets, government agencies, and consumers, and to provide information that is credible to the extent possible. However, we do not guarantee that this information is accurate or complete. Any views or opinions expressed on this site should not be considered as a substitute for advice from a licensed healthcare professional. This information is not meant to be a substitute for professional medical advice, diagnosis, or treatment. It is advised for potential misuse of antibiotics as well as for the safe use of the information on this page.This document contains an attempt to convert pricing to USD.The content on this page contains an attempt to convert pricing to USD.Bactrim (Sulfamethoxazole/Trimethoprim) can be purchased by calling +1-888-704-0408 and talking with a customer service representative, or by placing an online order at liferxpharmacy.com. Customer Support is also aided by using the chat feature. For additional information, visit the "How to Order" page on liferxpharmacy.com.
Bactrim (Sulfamethoxazole/Trimethoprim) is a medication that can only be purchased with a doctors prescription. While processing your order for the medication, it is necessary to get a valid prescription from your doctor The prescription can be scanned, emailed, or uploaded at liferxpharmacy.com or fax on +1-800-986-4751 Alternatively, if you like, we can even contact your doctor to obtain a valid prescription.
The maximum amount of Bactrim (Sulfamethoxazole/Trimethoprim) can be ordered at one time is a 90-day supply. The amount that can be ordered is dependent on the instructions and quantity mentioned on your medical prescription. Refilling alternate is always available for future needs.
It is a completely safe and secure choice to order your medicine from us. We function similarly alike any other traditional pharmacy, intending to serve safe and affordable prescription medicines. Our associated pharmacists are functional in many countries and are completely licensed and certified.
Bactrim (Sulfamethoxazole/Trimethoprim) is available in both generic and brand form. Generic medicines contain the same active components as brand-name pharmaceuticals have. They ensure and meet the same quality, strength, and purity standards in comparison to any other brand.
Yes. We deliver all around the United States and other major countries.
LifeRx pharmacy makes it simple to refill your medication. By going to your accounts reorder section, you can easily place a refill option available online. You may examine your prior orders and choose which prescriptions order needs to be refilled. To order a refill, you can also call us and chat with one of our customer service representatives. Our live chat is also one of the convenient ways to reach out to us while placing a refill order.
We do not automatically refill prescriptions as it might be the case where you may no longer be taking the same medicines or your doctor may have revised your dose, among other things. However, we do offer a helpful refill reminder service. Based on your prescription history, we may call or email you to let you know when the ideal time is to place a refill order.
Approved Federal Reserve Bank of the timeBuy Bactrim (Sulfamethoxazole/Trimethoprim) online for $19.99 - FDA approvedPrescription WARNINGalli, Jan. 2023 (scope: -ot-earcher)
Bactrim (Sulfamethoxazole/Trimethoprim) tabletsBactrim (Sulfamethoxazole/Trimethoprim) is a medication that can be used by adult patients to treat various bacterial and parasitic infections of the body.
Stade de France Pharmacy